atrasentan has been researched along with Glioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carson, KA; Desideri, S; Fisher, JD; Grossman, SA; Lesser, G; Mikkelsen, T; Olson, J; Phuphanich, S | 1 |
1 other study(ies) available for atrasentan and Glioma
| Article | Year |
|---|---|
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Agents; Atrasentan; Brain Neoplasms; Dose-Response Relationship, Drug; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pyrrolidines | 2008 |